---
kind: "section"
citation: "42 U.S.C. § 2160e"
title: "42"
title_heading: "The Public Health and Welfare"
number: "2160e"
heading: "Congressional review and oversight of agreements with Iran"
release: "119-102"
url: "https://uscodex.org/usc/42/2160e"
units:
  - "Chapter 23 — Development and Control of Atomic Energy"
  - "Division A — Atomic Energy"
  - "Subchapter X — International Activities"
---

# §2160e. Congressional review and oversight of agreements with Iran

- (a) **Transmission to Congress of nuclear agreements with Iran and verification assessment with respect to such agreements—**
  - (1) **Transmission of agreements—** Not later than 5 calendar days after reaching an [agreement](#h-1) with Iran relating to the nuclear [program](/usc/42/274l–1.md?p=4) of Iran, the President shall transmit to the [appropriate congressional committees and leadership](#h-3)—
    - (A) the [agreement](#h-1), as defined in [subsection (h)(1)](#h-1), including all related materials and annexes;
    - (B) a verification assessment report of the Secretary of State prepared under [paragraph (2)](#a-2) with respect to the [agreement](#h-1); and
    - (C) a certification that—
      - (i) the [agreement](#h-1) includes the appropriate terms, conditions, and duration of the [agreement](#h-1)’s requirements with respect to Iran’s nuclear activities and provisions describing any sanctions to be waived, suspended, or otherwise reduced by the [United States](/usc/42/403.md?p=k), and any other nation or entity, including the United Nations; and
      - (ii) the President determines the [agreement](#h-1) meets [United States](/usc/42/403.md?p=k) non-proliferation objectives, does not jeopardize the common defense and security, provides an adequate framework to ensure that Iran’s nuclear activities permitted thereunder will not be inimical to or constitute an unreasonable risk to the common defense and security, and ensures that Iran’s nuclear activities permitted thereunder will not be used to further any nuclear-related military or nuclear explosive purpose, including for any research on or development of any nuclear explosive device or any other nuclear-related military purpose.
  - (2) **Verification assessment report—**
    - (A) **In general—** The Secretary of State shall prepare, with respect to an [agreement](#h-1) described in [paragraph (1)](#a-1), a report assessing—
      - (i) the extent to which the [Secretary](/usc/42/242q–4.md?p=2) will be able to verify that Iran is complying with its obligations and commitments under the [agreement](#h-1);
      - (ii) the adequacy of the safeguards and other control mechanisms and other assurances contained in the [agreement](#h-1) with respect to Iran’s nuclear [program](/usc/42/274l–1.md?p=4) to ensure Iran’s activities permitted thereunder will not be used to further any nuclear-related military or nuclear explosive purpose, including for any research on or development of any nuclear explosive device or any other nuclear-related military purpose; and
      - (iii) the capacity and capability of the International Atomic [Energy](/usc/42/6311.md?p=7) [Agency](/usc/42/2231.md?p=a) to effectively implement the verification regime required by or related to the [agreement](#h-1), including whether the International Atomic [Energy](/usc/42/6311.md?p=7) [Agency](/usc/42/2231.md?p=a) will have sufficient access to investigate suspicious sites or allegations of covert nuclear-related activities and whether it has the required funding, manpower, and authority to undertake the verification regime required by or related to the [agreement](#h-1).
    - (B) **Assumptions—** In preparing a report under [subparagraph (A)](#a-2-A) with respect to an [agreement](#h-1) described in [paragraph (1)](#a-1), the [Secretary](/usc/42/242q–4.md?p=2) shall assume that Iran could—
      - (i) use all measures not expressly prohibited by the [agreement](#h-1) to conceal activities that violate its obligations and commitments under the [agreement](#h-1); and
      - (ii) alter or deviate from [standard](/usc/42/1320d.md?p=7) [practices](/usc/42/17061.md?p=19) in order to impede efforts to verify that Iran is complying with those obligations and commitments.
    - (C) **Classified annex—** A report under [subparagraph (A)](#a-2-A) shall be transmitted in unclassified form, but shall include a classified annex prepared in consultation with the [Director](/usc/42/5061.md?p=1) of National Intelligence, summarizing relevant classified information.
  - (3) **Exception—**
    - (A) **In general—** Neither the requirements of subparagraphs [(B)](#a-1-B) and [(C)](#a-1-C) of paragraph (1), nor [subsections (b) through (g)](#b..g) of this section, shall apply to an [agreement](#h-1) described in [subsection (h)(5)](#h-5) or to the [EU-Iran Joint Statement](#h-6) made on April 2, 2015.
    - (B) **Additional requirement—** Notwithstanding [subparagraph (A)](#a-3-A), any [agreement](#h-1) as defined in [subsection (h)(1)](#h-1) and any related materials, whether concluded before or after May 22, 2015, shall not be subject to the exception in [subparagraph (A)](#a-3-A).
- (b) **Period for review by Congress of nuclear agreements with Iran—**
  - (1) **In general—** During the 30-calendar day period following [transmittal](#b-7) by the President of an [agreement](#h-1) pursuant to [subsection (a)](#a), the Committee on Foreign Relations of the Senate and the Committee on Foreign Affairs of the House of [Representatives](/usc/42/3058f.md?p=5) shall, as appropriate, hold hearings and briefings and otherwise obtain information in order to fully review such [agreement](#h-1).
  - (2) **Exception—** The period for congressional review under [paragraph (1)](#b-1) shall be 60 calendar days if an [agreement](#h-1), including all materials required to be transmitted to Congress pursuant to [subsection (a)(1)](#a-1), is transmitted pursuant to [subsection (a)](#a) between July 10, 2015, and September 7, 2015.
  - (3) **Limitation on actions during initial congressional review period—** Notwithstanding any other provision of law, except as provided in [paragraph (6)](#b-6), prior to and during the period for [transmission](#b-7) of an [agreement](#h-1) in [subsection (a)(1)](#a-1) and during the period for congressional review provided in [paragraph (1)](#b-1), including any additional period as applicable under the exception provided in [paragraph (2)](#b-2), the President may not waive, suspend, reduce, provide relief from, or otherwise limit the application of statutory sanctions with respect to Iran under any provision of law or refrain from applying any such sanctions pursuant to an [agreement](#h-1) described in [subsection (a)](#a).
  - (4) **Limitation on actions during presidential consideration of a joint resolution of disapproval—** Notwithstanding any other provision of law, except as provided in [paragraph (6)](#b-6), if a joint resolution of disapproval described in [subsection (c)(2)(B)](#c-2-B) passes both Houses of Congress, the President may not waive, suspend, reduce, provide relief from, or otherwise limit the application of statutory sanctions with respect to Iran under any provision of law or refrain from applying any such sanctions pursuant to an [agreement](#h-1) described in [subsection (a)](#a) for a period of 12 calendar days following the date of such passage.
  - (5) **Limitation on actions during congressional reconsideration of a joint resolution of disapproval—** Notwithstanding any other provision of law, except as provided in [paragraph (6)](#b-6), if a joint resolution of disapproval described in [subsection (c)(2)(B)](#c-2-B) passes both Houses of Congress, and the President vetoes such joint resolution, the President may not waive, suspend, reduce, provide relief from, or otherwise limit the application of statutory sanctions with respect to Iran under any provision of law or refrain from applying any such sanctions pursuant to an [agreement](#h-1) described in [subsection (a)](#a) for a period of 10 calendar days following the date of the President’s veto.
  - (6) **Exception—** The prohibitions under [paragraphs (3) through (5)](#b-3..b-5) do not apply to any new deferral, waiver, or other suspension of statutory sanctions pursuant to the [Joint Plan of Action](#h-5) if that deferral, waiver, or other suspension is made—
    - (A) consistent with the law in effect on May 22, 2015; and
    - (B) not later than 45 calendar days before the [transmission](#b-7) by the President of an [agreement](#h-1), assessment report, and certification under [subsection (a)](#a).
  - (7) **Definition—** In the House of [Representatives](/usc/42/3058f.md?p=5), for purposes of this subsection, the terms “transmittal,” “transmitted,” and “transmission” mean transmittal, transmitted, and transmission, respectively, to the Speaker of the House of [Representatives](/usc/42/3058f.md?p=5).
- (c) **Effect of congressional action with respect to nuclear agreements with Iran—**
  - (1) **Sense of Congress—** It is the sense of Congress that—
    - (A) the sanctions regime imposed on Iran by Congress is primarily responsible for bringing Iran to the table to negotiate on its nuclear [program](/usc/42/274l–1.md?p=4);
    - (B) these negotiations are a critically important matter of national security and foreign policy for the [United States](/usc/42/403.md?p=k) and its closest allies;
    - (C) this section does not require a vote by Congress for the [agreement](#h-1) to commence;
    - (D) this section provides for congressional review, including, as appropriate, for approval, disapproval, or no action on statutory sanctions relief under an [agreement](#h-1); and
    - (E) even though the [agreement](#h-1) may commence, because the sanctions regime was imposed by Congress and only Congress can permanently modify or eliminate that regime, it is critically important that Congress have the opportunity, in an orderly and deliberative manner, to consider and, as appropriate, take action affecting the statutory sanctions regime imposed by Congress.
  - (2) **In general—** Notwithstanding any other provision of law, action involving any measure of statutory sanctions relief by the [United States](/usc/42/403.md?p=k) pursuant to an [agreement](#h-1) subject to [subsection (a)](#a) or the [Joint Plan of Action](#h-5)—
    - (A) may be taken, consistent with existing statutory requirements for such action, if, during the period for review provided in [subsection (b)](#b), there is enacted a joint resolution stating in substance that the Congress does favor the [agreement](#h-1);
    - (B) may not be taken if, during the period for review provided in [subsection (b)](#b), there is enacted a joint resolution stating in substance that the Congress does not favor the [agreement](#h-1); or
    - (C) may be taken, consistent with existing statutory requirements for such action, if, following the period for review provided in [subsection (b)](#b), there is not enacted any such joint resolution.
  - (3) **Definition—** For the purposes of this subsection, the phrase “action involving any measure of statutory sanctions relief by the [United States](/usc/42/403.md?p=k)” shall include waiver, suspension, reduction, or other effort to provide relief from, or otherwise limit the application of statutory sanctions with respect to, Iran under any provision of law or any other effort to refrain from applying any such sanctions.
- (d) **Congressional oversight of Iranian compliance with nuclear agreements—**
  - (1) **In general—** The President shall keep the [appropriate congressional committees and leadership](#h-3) fully and currently informed of all aspects of Iranian compliance with respect to an [agreement](#h-1) subject to [subsection (a)](#a).
  - (2) **Potentially significant breaches and compliance incidents—** The President shall, within 10 calendar days of receiving credible and accurate information relating to a potentially significant breach or compliance incident by Iran with respect to an [agreement](#h-1) subject to [subsection (a)](#a), submit such information to the [appropriate congressional committees and leadership](#h-3).
  - (3) **Material breach report—** Not later than 30 calendar days after submitting information about a potentially significant breach or compliance incident pursuant to [paragraph (2)](#d-2), the President shall make a determination whether such potentially significant breach or compliance issue constitutes a material breach and, if there is such a material breach, whether Iran has cured such material breach, and shall submit to the [appropriate congressional committees and leadership](#h-3) such determination, accompanied by, as appropriate, a report on the action or failure to act by Iran that led to the material breach, actions necessary for Iran to cure the breach, and the status of Iran’s efforts to cure the breach.
  - (4) **Semi-annual report—** Not later than 180 calendar days after entering into an [agreement](#h-1) described in [subsection (a)](#a), and not less frequently than once every 180 calendar days thereafter, the President shall submit to the [appropriate congressional committees and leadership](#h-3) a report on Iran’s nuclear [program](/usc/42/274l–1.md?p=4) and the compliance of Iran with the [agreement](#h-1) during the period covered by the report, including the following elements:
    - (A) Any action or failure to act by Iran that breached the [agreement](#h-1) or is in noncompliance with the terms of the [agreement](#h-1).
    - (B) Any delay by Iran of more than one week in providing inspectors access to [facilities](/usc/42/11049.md?p=4), people, and documents in Iran as required by the [agreement](#h-1).
    - (C) Any progress made by Iran to resolve concerns by the International Atomic [Energy](/usc/42/6311.md?p=7) [Agency](/usc/42/2231.md?p=a) about possible military dimensions of Iran’s nuclear [program](/usc/42/274l–1.md?p=4).
    - (D) Any procurement by Iran of materials in [violation](/usc/42/2000e–16a.md?p=c) of the [agreement](#h-1) or which could otherwise significantly advance Iran’s ability to obtain a nuclear weapon.
    - (E) Any centrifuge research and development conducted by Iran that—
      - (i) is not in compliance with the [agreement](#h-1); or
      - (ii) may substantially reduce the breakout time of acquisition of a nuclear weapon by Iran, if deployed.
    - (F) Any diversion by Iran of uranium, carbon-fiber, or other materials for use in Iran’s nuclear [program](/usc/42/274l–1.md?p=4) in [violation](/usc/42/2000e–16a.md?p=c) of the [agreement](#h-1).
    - (G) Any covert nuclear activities undertaken by Iran, including any covert nuclear weapons-related or covert fissile material activities or research and development.
    - (H) An assessment of whether any [Iranian financial institutions](#h-4) are engaged in money laundering or terrorist finance activities, including names of specific [financial institutions](/usc/42/666.md?p=a-17-D-i) if applicable.
    - (I) Iran’s advances in its ballistic missile [program](/usc/42/274l–1.md?p=4), including developments related to its long-range and inter-continental ballistic missile [programs](/usc/42/274l–1.md?p=4).
    - (J) An assessment of—
      - (i) whether Iran directly supported, financed, planned, or carried out an act of terrorism against the [United States](/usc/42/403.md?p=k) or a [United States person](#h-10) anywhere in the world;
      - (ii) whether, and the extent to which, Iran supported acts of terrorism, including acts of terrorism against the [United States](/usc/42/403.md?p=k) or a [United States person](#h-10) anywhere in the world;
      - (iii) all actions, including in international fora, being taken by the [United States](/usc/42/403.md?p=k) to stop, counter, and condemn acts by Iran to directly or indirectly carry out acts of terrorism against the [United States](/usc/42/403.md?p=k) and [United States persons](#h-10);
      - (iv) the impact on the national security of the [United States](/usc/42/403.md?p=k) and the safety of [United States](/usc/42/403.md?p=k) citizens as a result of any Iranian actions reported under this paragraph; and
      - (v) all of the sanctions relief provided to Iran, pursuant to the [agreement](#h-1), and a description of the relationship between each sanction waived, suspended, or deferred and Iran’s nuclear weapon’s [program](/usc/42/274l–1.md?p=4).
    - (K) An assessment of whether [violations](/usc/42/2000e–16a.md?p=c) of internationally recognized human rights in Iran have changed, increased, or decreased, as compared to the prior 180-day period.
  - (5) **Additional reports and information—**
    - (A) **Agency reports—** Following submission of an [agreement](#h-1) pursuant to [subsection (a)](#a) to the [appropriate congressional committees and leadership](#h-3), the Department of State, the Department of [Energy](/usc/42/6311.md?p=7), and the Department of Defense shall, upon the request of any of those committees or leadership, promptly furnish to those committees or leadership their views as to whether the safeguards and other controls contained in the [agreement](#h-1) with respect to Iran’s nuclear [program](/usc/42/274l–1.md?p=4) provide an adequate framework to ensure that Iran’s activities permitted thereunder will not be inimical to or constitute an unreasonable risk to the common defense and security.
    - (B) **Provision of information on nuclear initiatives with Iran—** The President shall keep the [appropriate congressional committees and leadership](#h-3) fully and currently informed of any [initiative](/usc/42/19131.md?p=1) or negotiations with Iran relating to Iran’s nuclear [program](/usc/42/274l–1.md?p=4), including any new or amended [agreement](#h-1).
  - (6) **Compliance certification—** After the review period provided in [subsection (b)](#b), the President shall, not less than every 90 calendar days—
    - (A) determine whether the President is able to certify that—
      - (i) Iran is transparently, verifiably, and fully implementing the [agreement](#h-1), including all related technical or additional [agreements](#h-1);
      - (ii) Iran has not committed a material breach with respect to the [agreement](#h-1) or, if Iran has committed a material breach, Iran has cured the material breach;
      - (iii) Iran has not taken any action, including covert activities, that could significantly advance its nuclear weapons [program](/usc/42/274l–1.md?p=4); and
      - (iv) suspension of sanctions related to Iran pursuant to the [agreement](#h-1) is—
        - (I) appropriate and proportionate to the specific and verifiable measures taken by Iran with respect to terminating its [illicit](/usc/42/11851.md?p=6) nuclear [program](/usc/42/274l–1.md?p=4); and
        - (II) vital to the national security interests of the [United States](/usc/42/403.md?p=k); and
    - (B) if the President determines he is able to make the certification described in [subparagraph (A)](#d-6-A), make such certification to the [appropriate congressional committees and leadership](#h-3).
  - (7) **Sense of Congress—** It is the sense of Congress that—
    - (A) [United States](/usc/42/403.md?p=k) sanctions on Iran for terrorism, human rights abuses, and ballistic missiles will remain in place under an [agreement](#h-1), as defined in [subsection (h)(1)](#h-1);
    - (B) issues not addressed by an [agreement](#h-1) on the nuclear [program](/usc/42/274l–1.md?p=4) of Iran, including fair and appropriate compensation for Americans who were terrorized and subjected to torture while held in captivity for 444 days after the seizure of the [United States](/usc/42/403.md?p=k) Embassy in Tehran, Iran, in 1979 and their [families](/usc/42/12704.md?p=11), the freedom of Americans held in Iran, the human rights abuses of the Government of Iran against its own people, and the continued support of terrorism worldwide by the Government of Iran, are matters critical to ensure justice and the national security of the [United States](/usc/42/403.md?p=k), and should be expeditiously addressed;
    - (C) the President should determine the [agreement](#h-1) in no way compromises the commitment of the [United States](/usc/42/403.md?p=k) to Israel’s security, nor its support for Israel’s right to exist; and
    - (D) in order to responsibly implement any long-term [agreement](#h-1) reached between the [P5+1 countries](#h-9) and Iran, it is critically important that Congress have the opportunity to review any [agreement](#h-1) and, as necessary, take action to modify the statutory sanctions regime imposed by Congress.
- (e) **Expedited consideration of legislation—**
  - (1) **Initiation—**
    - (A) **In general—** In the event the President does not [submit](#e-1-B) a certification pursuant to [subsection (d)(6)](#d-6) during each 90-day period following the review period provided in [subsection (b)](#b), or [submits](#e-1-B) a determination pursuant to [subsection (d)(3)](#d-3) that Iran has materially breached an [agreement](#h-1) subject to [subsection (a)](#a) and the material breach has not been cured, [qualifying legislation](#e-2) introduced within 60 calendar days of such event shall be entitled to expedited consideration pursuant to this subsection.
    - (B) **Definition—** In the House of [Representatives](/usc/42/3058f.md?p=5), for purposes of this paragraph, the terms “submit” and “submits” mean submit and submits, respectively, to the Speaker of the House of [Representatives](/usc/42/3058f.md?p=5).
  - (2) **Qualifying legislation defined—** For purposes of this subsection, the term “qualifying legislation” means only a bill of either House of Congress—
    - (A) the title of which is as follows: “A bill reinstating statutory sanctions imposed with respect to Iran.”; and
    - (B) the matter after the enacting clause of which is: “Any statutory sanctions imposed with respect to Iran pursuant to ______ that were waived, suspended, reduced, or otherwise relieved pursuant to an [agreement](#h-1) submitted pursuant to section 135(a) of the Atomic Energy Act of 1954 are hereby reinstated and any action by the [United States](/usc/42/403.md?p=k) Government to facilitate the [release](/usc/42/9601.md?p=22) of [funds](/usc/42/12854.md?p=3) or assets to Iran pursuant to such [agreement](#h-1), or provide any further waiver, suspension, reduction, or other relief pursuant to such [agreement](#h-1) is hereby prohibited.”, with the blank space being filled in with the law or laws under which sanctions are to be reinstated.
  - (3) **Introduction—** During the 60-calendar day period provided for in [paragraph (1)](#e-1), [qualifying legislation](#e-2) may be introduced—
    - (A) in the House of [Representatives](/usc/42/3058f.md?p=5), by the majority leader or the [minority](/usc/42/299a–1.md?p=d-2) leader; and
    - (B) in the Senate, by the majority leader (or the majority leader’s designee) or the [minority](/usc/42/299a–1.md?p=d-2) leader (or the [minority](/usc/42/299a–1.md?p=d-2) leader’s designee).
  - (4) **Floor consideration in House of Representatives—**
    - (A) **Reporting and discharge—** If a committee of the House to which [qualifying legislation](#e-2) has been referred has not reported such [qualifying legislation](#e-2) within 10 legislative days after the date of referral, that committee shall be discharged from further consideration thereof.
    - (B) **Proceeding to consideration—** Beginning on the third legislative day after each committee to which [qualifying legislation](#e-2) has been referred reports it to the House or has been discharged from further consideration thereof, it shall be in order to move to proceed to consider the [qualifying legislation](#e-2) in the House. All points of order against the motion are waived. Such a motion shall not be in order after the House has disposed of a motion to proceed on the [qualifying legislation](#e-2) with regard to the same [agreement](#h-1). The previous question shall be considered as ordered on the motion to its adoption without intervening motion. The motion shall not be debatable. A motion to reconsider the vote by which the motion is disposed of shall not be in order.
    - (C) **Consideration—** The [qualifying legislation](#e-2) shall be considered as read. All points of order against the [qualifying legislation](#e-2) and against its consideration are waived. The previous question shall be considered as ordered on the [qualifying legislation](#e-2) to final passage without intervening motion except two hours of debate equally divided and controlled by the sponsor of the [qualifying legislation](#e-2) (or a designee) and an opponent. A motion to reconsider the vote on passage of the [qualifying legislation](#e-2) shall not be in order.
  - (5) **Consideration in the Senate—**
    - (A) **Committee referral—** [Qualifying legislation](#e-2) introduced in the Senate shall be referred to the Committee on Foreign Relations.
    - (B) **Reporting and discharge—** If the Committee on Foreign Relations has not reported such [qualifying legislation](#e-2) within 10 session days after the date of referral of such legislation, that committee shall be discharged from further consideration of such legislation and the [qualifying legislation](#e-2) shall be placed on the appropriate calendar.
    - (C) **Proceeding to consideration—** Notwithstanding Rule XXII of the Standing Rules of the Senate, it is in order at any time after the committee authorized to consider [qualifying legislation](#e-2) reports it to the Senate or has been discharged from its consideration (even though a previous motion to the same effect has been disagreed to) to move to proceed to the consideration of [qualifying legislation](#e-2), and all points of order against [qualifying legislation](#e-2) (and against consideration of the [qualifying legislation](#e-2)) are waived. The motion to proceed is not debatable. The motion is not subject to a motion to postpone. A motion to reconsider the vote by which the motion is agreed to or disagreed to shall not be in order. If a motion to proceed to the consideration of the [qualifying legislation](#e-2) is agreed to, the [qualifying legislation](#e-2) shall remain the unfinished business until disposed of.
    - (D) **Debate—** Debate on [qualifying legislation](#e-2), and on all debatable motions and appeals in connection therewith, shall be limited to not more than 10 hours, which shall be divided equally between the majority and [minority](/usc/42/299a–1.md?p=d-2) leaders or their designees. A motion to further limit debate is in order and not debatable. An amendment to, or a motion to postpone, or a motion to proceed to the consideration of other business, or a motion to recommit the [qualifying legislation](#e-2) is not in order.
    - (E) **Vote on passage—** The vote on passage shall occur immediately following the conclusion of the debate on the [qualifying legislation](#e-2) and a [single](/usc/42/2304.md?p=m) quorum call at the conclusion of the debate, if requested in accordance with the rules of the Senate.
    - (F) **Rulings of the Chair on procedure—** Appeals from the decisions of the Chair relating to the application of the rules of the Senate, as the case may be, to the procedure relating to [qualifying legislation](#e-2) shall be decided without debate.
    - (G) **Consideration of veto messages—** Debate in the Senate of any veto message with respect to [qualifying legislation](#e-2), including all debatable motions and appeals in connection with such [qualifying legislation](#e-2), shall be limited to 10 hours, to be equally divided between, and controlled by, the majority leader and the [minority](/usc/42/299a–1.md?p=d-2) leader or their designees.
  - (6) **Rules relating to Senate and House of Representatives—**
    - (A) **Coordination with action by other House—** If, before the passage by one House of [qualifying legislation](#e-2) of that House, that House receives [qualifying legislation](#e-2) from the other House, then the following procedures shall apply:
      - (i) The [qualifying legislation](#e-2) of the other House shall not be referred to a committee.
      - (ii) With respect to [qualifying legislation](#e-2) of the House receiving the legislation—
        - (I) the procedure in that House shall be the same as if no [qualifying legislation](#e-2) had been received from the other House; but
        - (II) the vote on passage shall be on the [qualifying legislation](#e-2) of the other House.
    - (B) **Treatment of a bill of other House—** If one House fails to introduce [qualifying legislation](#e-2) under this section, the [qualifying legislation](#e-2) of the other House shall be entitled to expedited floor procedures under this section.
    - (C) **Treatment of companion measures—** If, following passage of the [qualifying legislation](#e-2) in the Senate, the Senate then receives a companion measure from the House of [Representatives](/usc/42/3058f.md?p=5), the companion measure shall not be debatable.
    - (D) **Application to revenue measures—** The provisions of this paragraph shall not apply in the House of [Representatives](/usc/42/3058f.md?p=5) to [qualifying legislation](#e-2) which is a revenue measure.
- (f) **Rules of House of Representatives and Senate—** [Subsection (e)](#e) is enacted by Congress—
  - (1) as an exercise of the rulemaking power of the Senate and the House of [Representatives](/usc/42/3058f.md?p=5), respectively, and as such are deemed a part of the rules of each House, respectively, but applicable only with respect to the procedure to be followed in that House in the case of legislation described in those sections, and supersede other rules only to the extent that they are inconsistent with such rules; and
  - (2) with full recognition of the constitutional right of either House to change the rules (so far as relating to the procedure of that House) at any time, in the same manner, and to the same extent as in the case of any other rule of that House.
- (g) **Rules of construction—** Nothing in the section shall be construed as—
  - (1) modifying, or having any other impact on, the President’s authority to negotiate, enter into, or implement appropriate executive [agreements](#h-1), other than the restrictions on implementation of the [agreements](#h-1) specifically covered by this section;
  - (2) allowing any new waiver, suspension, reduction, or other relief from statutory sanctions with respect to Iran under any provision of law, or allowing the President to refrain from applying any such sanctions pursuant to an [agreement](#h-1) described in [subsection (a)](#a) during the period for review provided in [subsection (b)](#b);
  - (3) revoking or terminating any statutory sanctions imposed on Iran; or
  - (4) authorizing the use of military force against Iran.
- (h) **Definitions—** In this section:
  - (1) **Agreement—** The term “agreement” means an agreement related to the nuclear [program](/usc/42/274l–1.md?p=4) of Iran that includes the [United States](/usc/42/403.md?p=k), commits the [United States](/usc/42/403.md?p=k) to take action, or pursuant to which the [United States](/usc/42/403.md?p=k) commits or otherwise agrees to take action, regardless of the form it takes, whether a political commitment or otherwise, and regardless of whether it is legally binding or not, including any joint comprehensive plan of action entered into or made between Iran and any other parties, and any additional materials related thereto, including annexes, appendices, codicils, side agreements, implementing materials, documents, and guidance, technical or other understandings, and any related agreements, whether entered into or implemented prior to the agreement or to be entered into or implemented in the future.
  - (2) **Appropriate congressional committees—** The term “appropriate congressional committees” means the Committee on Finance, the Committee on Banking, [Housing](/usc/42/1490p–2.md?p=r-3), and Urban Affairs, the Select Committee on Intelligence, and the Committee on Foreign Relations of the Senate and the Committee on Ways and Means, the Committee on Financial Services, the Permanent Select Committee on Intelligence, and the Committee on Foreign Affairs of the House of [Representatives](/usc/42/3058f.md?p=5).
  - (3) **Appropriate congressional committees and leadership—** The term “appropriate congressional committees and leadership” means the Committee on Finance, the Committee on Banking, [Housing](/usc/42/1490p–2.md?p=r-3), and Urban Affairs, the Select Committee on Intelligence, and the Committee on Foreign Relations, and the Majority and [Minority](/usc/42/299a–1.md?p=d-2) Leaders of the Senate and the Committee on Ways and Means, the Committee on Financial Services, the Permanent Select Committee on Intelligence, and the Committee on Foreign Affairs, and the Speaker, Majority Leader, and [Minority](/usc/42/299a–1.md?p=d-2) Leader of the House of [Representatives](/usc/42/3058f.md?p=5).
  - (4) **Iranian financial institution—** The term “Iranian financial institution” has the meaning given the term in [section 8513b(d) of title 22](/usc/22/8513b.md?p=d).
  - (5) **Joint Plan of Action—** The term “Joint Plan of Action” means the Joint Plan of Action, signed at Geneva November 24, 2013, by Iran and by France, Germany, the Russian Federation, the People’s Republic of China, the United Kingdom, and the [United States](/usc/42/403.md?p=k), and all implementing materials and [agreements](#h-1) related to the Joint Plan of Action, including the technical understandings reached on January 12, 2014, the extension thereto agreed to on July 18, 2014, the extension agreed to on November 24, 2014, and any materially identical extension that is agreed to on or after May 22, 2015.
  - (6) **EU-Iran Joint Statement—** The term “EU-Iran Joint Statement” means only the Joint Statement by EU High [Representative](/usc/42/3058f.md?p=5) Federica Mogherini and Iranian Foreign Minister Javad Zarif made on April 2, 2015, at Lausanne, Switzerland.
  - (7) **Material breach—** The term “material breach” means, with respect to an [agreement](#h-1) described in [subsection (a)](#a), any breach of the [agreement](#h-1), or in the case of non-binding commitments, any failure to perform those commitments, that substantially—
    - (A) benefits Iran’s nuclear [program](/usc/42/274l–1.md?p=4);
    - (B) decreases the amount of time required by Iran to achieve a nuclear weapon; or
    - (C) deviates from or undermines the purposes of such [agreement](#h-1).
  - (8) **Noncompliance defined—** The term “noncompliance” means any departure from the terms of an [agreement](#h-1) described in [subsection (a)](#a) that is not a material breach.
  - (9) **P5+1 countries—** The term “P5+1 countries” means the [United States](/usc/42/403.md?p=k), France, the Russian Federation, the People’s Republic of China, the United Kingdom, and Germany.
  - (10) **United States person—** The term “United States person” has the meaning given that term in [section 8511 of title 22](/usc/22/8511.md).

## Source credit

(Aug. 1, 1946, ch. 724, title I, § 135, as added Pub. L. 114–17, § 2, May 22, 2015, 129 Stat. 201.)

## Notes

### Executive Documents

### Delegation of Certain Functions and Authorities Under Section 135 of the Atomic Energy Act of 1954 (42 U.S.C. 2011 et seq.), as amended by the Iran Nuclear Agreement Review Act of 2015

Memorandum of President of the United States, July 17, 2015, 80 F.R. 43909, provided:

Memorandum for the Secretary of State [and] the Secretary of the Treasury

By the authority vested in me as President by the Constitution and the laws of the United States of America, including section 301 of title 3 of the United States Code, I hereby order as follows:

I hereby delegate the functions and authorities vested in the President by the following provisions of section 135 of the Atomic Energy Act of 1954 (42 U.S.C. 2011 et seq.), as amended by the Iran Nuclear Agreement Review Act of 2015, as follows:

• Section 135(a)(1) to the Secretary of State, in consultation with the Secretary of the Treasury as appropriate;

• Sections 135(d)(1)–(d)(3), (d)(5)(B), and (d)(6) to the Secretary of State, in consultation with other relevant agencies as appropriate;

• Section 135(d)(4) to the Secretary of State, in consultation with the Secretary of the Treasury as appropriate, with respect to the requirement to submit the report described in that provision and to prepare each of the required elements of the report, with the exception of the required assessment related to money laundering or terrorist finance activities in section 135(d)(4)(H);

• Section 135(d)(4)(H) to the Secretary of the Treasury, in consultation with the Secretary of State, with respect to preparation of the assessment described in that provision for inclusion in the report required by section 135(d)(4).

Any reference in this memorandum to provisions of any act related to the subject of this memorandum shall be deemed to include references to any hereafter enacted provisions of law that are the same or substantially the same as such provisions.

The Secretary of State is authorized and directed to publish this memorandum in the Federal Register.